Skip to content

IMDX IMDX Investing Cash Flow

Investing Cash Flow at other companies

CareDx logo
CareDxCDNA
$11.06M+735%
Guardant Health logo
Guardant HealthGH
$699.42M+131%
Natera, Inc. logo
Natera, Inc.NTRA
-$32.14M-91.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$10.94M-60.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$93.2M-3,314%
Agilent Technologies logo
Agilent TechnologiesA
-$77M+32.5%

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's investing cash flow?
IMDX (IMDX) reported investing cash flow of -$613K in Q1 2026.
How has IMDX's investing cash flow changed year-over-year?
IMDX's investing cash flow decreased by 99.7% year-over-year, from -$307K to -$613K.
What is the long-term trend for IMDX's investing cash flow?
Over 3 years (2021 to 2025), IMDX's investing cash flow has grown at a -38.9% compound annual growth rate (CAGR), from -$13.96M to -$3.19M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.